VN October 2022

Vetnews | Oktober 2022 37 infiltrate is denser and deeper, resulting in a more opaque cornea. Because of the deeper corneal location, vascularisation is typically less branching and straighter than observed with superficial IMMKs. These cases are also generally less responsive to topical medications. Endothelial Immune-Mediated Keratitis (23% of cases) Also known as endotheliitis and is characterised by a chronic, slowly progressive, non-painful, diffuse ventro-lateral or ventral full thickness areaof corneal oedema.Whenexaminedwitha slit-lampbiomicroscope, dark cellular infiltrate can be observed at the edge of corneal oedema at the level of the endothelial cells. Occasionally with chronic disease, bullous keratopathy may develop with focal or multifocal superficial ulcers. When this happens, signs of ocular pain will be present. These eyes have a normal IOP and no aqueous flare. Treatment Initial aggressive use of topical glucocorticoids [Prednisolone acetate/ dexamethasone]andimmunosuppressiveagents[Cyclosporin/Tacrolimus]. Early intervention is indicated as these diseases become increasingly refractory tomedical therapyand increasingly liable to recurrencewith time. Treatment is often required for protracted periods to control the recrudescence of the disease. Usually, this involves tapering the frequency of topical administration of the medication to the minimum required to control the expression of the disease. Most cases can be managed with lifelong Tacrolimus/cyclosporin. Long-term client compliance is sometimes a problem. Treatment of immune-mediated keratitis in horses with episcleral silicone matrix cyclosporine delivery devices has been described with good long-term results. A single implant leads to the slow release of Cyclosporin for at least one year but up to two years. Implanting these devices is a straightforward procedure done under topical anaesthesia and regional nerve blocks in a standing patient. Cyclosporin implants are available in South Africa and are being compounded by VetScripts. Email info@vetscripts.co.za. For more information regarding implanting these devices, please email consult@dvos.co.za. v References: 1. Brian C. Gilger, et al. Treatment of immune-mediated keratitis in horses with episcleral silicone matrix cyclosporine delivery devices Veterinary Ophthalmology (2014) 17, Supplement 1, 23–30 2. A. Matthews, B. Gilger. Equine immune-mediated keratopathies. Equine veterinary journal equine vet. j., suppl. 37 (2010) 31-37 Regulars I Ophthalmology Column The first mission of DVOS is to create a platform for the general practitioner veterinary surgeon to improve their ophthalmological knowledge and enable them to deal with ocular cases with more confidence. This will be done with online courses allowing participants to download course material that will include written notes as well as narrated PowerPoint presentations. The first small animal course comprises of 240 pages and the PowerPoint lectures are 20 hours in total excluding a guest lecture on SARDS. I shall also make surgical videos available covering some common surgical procedures. The course is CPD accreditedwith the South AfricanVeterinary council for a total of 23 CPD points. The secondmission is toprovidea service to thepracticingveterinarianofferingspecialist advice regardingproblematic cases. More information regarding both of these aims are available on the website: www.dvos.co.za Figure 3 Midstromal IMMK Dense cellular infiltrate resulting in a more opaque cornea than superficial IMMK.

RkJQdWJsaXNoZXIy OTc5MDU=